Form 4: Lifevantage Director Boosts Stake with Stock Grant

Lifevantage Corp Director Cynthia Latham received a grant of 13,531 common shares valued at $7.76 per share as part of her compensation, increasing her total beneficial ownership.

Summary

• Cynthia Latham, a Director of Lifevantage Corp (LFVN), acquired 13,531 shares of common stock.
• The transaction occurred on November 6, 2025, with the shares granted as part of the issuer's outside director compensation program.
• The acquisition price was $7.76 per share, which represents the weighted average closing price of the issuer's common stock for the ten trading days ending the day before the grant date.
• These shares will vest in a single installment on November 6, 2026, contingent upon Ms. Latham's continuous service to Lifevantage Corp through that date.
• Following this transaction, Ms. Latham beneficially owns a total of 64,879 shares of Lifevantage Corp common stock.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive. While a routine compensation grant, it increases director ownership, which generally aligns management interests with shareholders. There are no negative implications for the company's operations or financial health.

Positives

• Increased director ownership aligns the interests of Cynthia Latham with those of shareholders, potentially fostering a stronger commitment to the company's long-term performance.
• The grant of shares as compensation is a standard practice for retaining and incentivizing key board members.

Risks

• The shares granted to Cynthia Latham are subject to a vesting condition, requiring her continuous service until November 6, 2026, which means the shares are not immediately fully owned and could be forfeited if service ceases.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future financial performance or strategic direction.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, specifically a stock grant to an outside director as part of their compensation. Such grants are common practice across industries to align director incentives with shareholder value.

Comparison to Industry Standards

• The practice of compensating outside directors with equity, such as stock grants, is a widely accepted corporate governance standard across various industries, including the health and wellness sector where Lifevantage operates. This aligns director interests with long-term shareholder value, similar to practices at comparable companies like Herbalife Nutrition Ltd. (HLF) or USANA Health Sciences, Inc. (USNA), which also utilize equity-based compensation for their non-employee directors.

Corporate Governance

Related Party Transactions

• The acquisition of 13,531 shares by Cynthia Latham, a director, as part of her compensation program, constitutes a related party transaction.

Stakeholder Impact

• Shareholders: Increased director ownership can be viewed positively as it aligns the director's financial interests with the company's performance, potentially benefiting long-term shareholder value.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• The 13,531 shares granted to Cynthia Latham are scheduled to vest on November 6, 2026, provided she continues her service as a director.

Key Dates

Keywords

Lifevantage, LFVN, Director Compensation, Stock Grant, Insider Transaction, Beneficial Ownership, SEC Form 4